Endoscopic bronchial valve treatment of bronchopleural fistala and air leakage

Drobyazgin, E. A.; Chikinev, Yu. V.; Судовых, И. Е.

doi:10.17116/hirurgia202005149

Cited by 7 publications

(2 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Another study of 115 BPF cases also showed that EBV treatment was effective in >70% of patients without related complications. 9 These studies show that EBV treatment is effective for BPF with relatively mild complications. Better treatment results can be achieved with sealing agents when the patient’s fistula is <5 mm, especially when it is ≤3 mm.…”

Section: Discussionmentioning

confidence: 88%

Complex bronchopleural fistulas: a case report

Cao,

Yi,

Bao

et al. 2024

J Int Med Res

View full text Add to dashboard Cite

Bronchopleural fistula (BPF) is a potentially fatal complication and remains a surgical challenge. Concomitant problems, such as pulmonary infection and respiratory failure, are typically the main contributors to mortality from BPF because of improper contact between the bronchial and pleural cavity. We present the case of a 75-year-old male patient with a history of right upper lobe lung cancer resection who developed complex BPFs. Following appropriate antibiotic therapy and chest tube drainage, we treated the fistulas using endobronchial valve EBV placement and local argon gas spray stimulation. Bronchoscopic treatment is the preferred method for patients who cannot tolerate a second surgery because it can help to maximize their quality of life. Our treatment method may be a useful reference for treating complex BPF.

show abstract

Section: Discussionmentioning

confidence: 88%

Complex bronchopleural fistulas: a case report

Cao,

Yi,

Bao

et al. 2024

J Int Med Res

View full text Add to dashboard Cite

show abstract

“…It can also be placed through a flexible bronchoscope under general or local anaesthesia. A recent study 27 observed that EBVs therapy was effective in more than 70% of patients with BPF and prolonged air leaks, with no intraoperative or 6 journals.sagepub.com/home/tar TherapeuTic advances in respiratory disease postoperative complications. An interesting finding is that a higher comorbidity burden appears to be a risk factor for delayed recovery, regardless of the EBVs implantation status.…”

Section: Endobronchial Valvesmentioning

confidence: 99%

Bronchoscopic interventions for bronchopleural fistulas

Jin

2023

Ther Adv Respir Dis

View full text Add to dashboard Cite

Bronchopleural fistula is a potentially fatal disease most often caused after pneumonectomy. Concomitant problems such as pulmonary infection and respiratory failure are typically the main contributors to patient mortality because of the improper contact between the bronchial and pleural cavity. Therefore, bronchopleural fistulas need immediate treatment, which requires the accurate location and timely closure of the fistula. Currently, bronchoscopic interventions, because of their flexibility and versatility, are reliable alternative therapies in patients for whom surgical intervention is unsuitable. Possible interventions include bronchoscopic placement of blocking agents, atrial septal defect (ASD)/ventricular septal defect (VSD) occluders, airway stents, endobronchial valves (EBVs) and endobronchial Watanabe spigots (EWSs). Recent developments in mesenchymal stem cells (MSCs) transplantation technology and three-dimensional (3D) printed stents have also contributed to the treatment of bronchopleural fistula, but more research is needed to investigate the long-term benefits. This review focuses on the effectiveness of various bronchoscopic measures for the treatment of bronchopleural fistula and the directions for future development.

show abstract